N A Le

Author PubWeight™ 52.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 1990 4.89
2 Cardiovascular disease risk factors among American Indians. The Strong Heart Study. Am J Epidemiol 1995 2.53
3 Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest 1986 1.96
4 Risk factors for coronary heart disease in diabetic and nondiabetic Native Americans. The Strong Heart Study. Diabetes 1992 1.67
5 Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice. Invest Ophthalmol Vis Sci 2000 1.65
6 Effects of exercise training and its cessation on components of the insulin resistance syndrome in obese children. Int J Obes Relat Metab Disord 1999 1.64
7 Visceral adipose tissue and cardiovascular risk factors in obese children. J Pediatr 1998 1.49
8 Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest 1982 1.39
9 Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins. Am J Physiol 1980 1.24
10 Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss. J Clin Invest 1985 1.23
11 Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med 1985 1.15
12 Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis. J Clin Invest 1987 1.14
13 Direct measurement of apoprotein B specific activity in 125I-labeled lipoproteins. J Lipid Res 1978 1.07
14 Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane. Arch Ophthalmol 2001 1.06
15 Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey. J Clin Invest 1988 1.05
16 Effect of changing dietary fat saturation on low-density lipoprotein metabolism in man. Am J Physiol 1981 1.04
17 Visceral adipose tissue and markers of the insulin resistance syndrome in obese black and white teenagers. Obes Res 2000 1.02
18 Effect of a high carbohydrate diet on apoprotein-B catabolism in man. Metabolism 1981 0.96
19 Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins. J Lipid Res 1985 0.96
20 Kinetics of chylomicron remnant clearance in normal and in hyperlipoproteinemic subjects. J Lipid Res 1987 0.95
21 An efficient chromatographic system for lipoprotein fractionation using whole plasma. J Lipid Res 1998 0.93
22 Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations. J Nucl Med 1988 0.92
23 Lipoprotein metabolism in nonresponders to increased dietary cholesterol. Arteriosclerosis 1982 0.91
24 Changes in lipoprotein concentrations during the development of noninsulin-dependent diabetes mellitus in obese rhesus monkeys (Macaca mulatta). J Clin Endocrinol Metab 1991 0.91
25 Metabolism of apoprotein B in cynomolgus monkey: evidence for independent production of low-density lipoprotein apoprotein B. Am J Physiol 1983 0.90
26 Evidence for heterogeneity of low-density lipoprotein metabolism in the cynomolgus monkey. Biochim Biophys Acta 1986 0.87
27 Apo E-mediated uptake and degradation of normal very low density lipoproteins by human monocyte/macrophages: a saturable pathway distinct from the LDL receptor. Biochem Biophys Res Commun 1985 0.87
28 Kinetic analysis using specific radioactivity data. Methods Enzymol 1986 0.87
29 Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins. HIV Med 2005 0.86
30 Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes. Diabet Med 2011 0.85
31 Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity. Diabetes Care 1994 0.85
32 Marked overproduction of low density lipoprotein apolipoprotein B in a subject with heterozygous familial hypercholesterolemia. Effect of portacaval shunting. Biochim Biophys Acta 1982 0.84
33 Familial combined hyperlipidaemia: use of stable isotopes to demonstrate overproduction of very low-density lipoprotein apolipoprotein B by the liver. J Inherit Metab Dis 1991 0.84
34 Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis. J Lipid Res 1989 0.83
35 Concentrations of Lp(a) in black and white young adults: relations to risk factors for cardiovascular disease. Ann Epidemiol 1994 0.83
36 Protocol for the study of the metabolism of retinyl esters in plasma lipoproteins during postprandial lipemia. J Lipid Res 1992 0.82
37 Increased low-density-lipoprotein catabolism in myeloproliferative disorders. Ann Intern Med 1982 0.82
38 Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins. J Lipid Res 1993 0.82
39 Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size. J Lipid Res 1999 0.81
40 Altered high density lipoprotein metabolism in patients with myeloproliferative disorders and hypocholesterolemia. Metabolism 1986 0.80
41 Effect of somatostatin-induced suppression of postprandial insulin response upon the hypertriglyceridemia associated with a high carbohydrate diet. J Clin Invest 1982 0.79
42 Direct determination of apolipoprotein C-III specific activity using immunoaffinity chromatography. Methods Enzymol 1986 0.79
43 Protocol for the preparation of a segmental linear polyacrylamide gradient gel: simultaneous determination of Lp[a], LDL, and HDL particle sizes. J Lipid Res 1997 0.79
44 The effect of lovastatin on very low-density lipoprotein apolipoprotein B production by the liver in familial combined hyperlipidaemia. J Inherit Metab Dis 1993 0.77
45 Direct measurement of apoprotein C-III specific activity in 125I-labeled very low density lipoproteins using immunoaffinity chromatography. J Lipid Res 1983 0.77
46 Determinants of fasting plasma triglyceride levels: metabolism of hepatic and intestinal lipoproteins. Eur J Clin Invest 1992 0.77
47 Increased catabolism of native and cyclohexanedione-modified low density lipoprotein in subjects with myeloproliferative diseases. Arteriosclerosis 1983 0.76
48 Immunoaffinity isolation of apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 1985 0.75
49 Juvenile neuronal ceroid-lipofuscinosis: characterization of the dyslipoproteinaemia and demonstration of membrane phospholipid and phospholipid-dependent signal transduction abnormalities in cultured skin fibroblasts. J Inherit Metab Dis 1993 0.75
50 Cardiovascular disease and hyperlipidaemia. Curr Opin Lipidol 1994 0.75
51 Hyperlipidemia and cardiovascular disease. Curr Opin Lipidol 1997 0.75
52 Binding affinity and particle size of LDL in subjects with moderate hypercholesterolemia: relationship with in vivo LDL metabolism. J Lipid Res 1996 0.75
53 Effect of acute intravenous alcohol on plasma lipoproteins in man. Metabolism 1991 0.75
54 Hyperlipidaemia and cardiovascular disease. Curr Opin Lipidol 1999 0.75
55 Hyperlipidaemia and cardiovascular disease. Curr Opin Lipidol 2001 0.75
56 Protocol for efficient plasma sampling for low density lipoprotein turnover studies. J Lipid Res 1984 0.75